Maxim Group Resumes MediciNova (MNOV) at Buy, PT $6
Maxim Group analyst Jason McCarthy resumes coverage on MediciNova (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
